Lynparza/Recentin Combo Fails In Phase III PSR Ovarian Cancer

Disappointment For AstraZeneca

 
• By Alexandra Shimmings
  
Ovarian cancer
Ovarian cancer is difficult to treat • Source: Shutterstock

More from Clinical Trials

More from R&D